PDCD1 and Sepsis: Immunosuppression, which is also known as “sepsis-induced immunoparalysis,” appears to be the lethal component of sepsis, rather than excessive immune activation (45) in which immunotherapies have shown preclinical and clinical promise with anti-PD1 mAbs having an effect in small clinical trials (46).